Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
14
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Ekblom Anders | Director | 6 | $0 | $0 | 2026-02-26 |
| Shames Daniel | Director | 6 | $0 | $0 | 2026-02-26 |
| Bender Jeremy | Director | 7 | $0 | $0 | 2026-02-26 |
| Jacquet Pierre | Director | 6 | $0 | $0 | 2026-02-26 |
| Jenkins Annalisa | Director | 6 | $0 | $0 | 2026-02-26 |
| Yoskowitz Marc J | Director | 6 | $0 | $0 | 2026-02-26 |
| PAKIANATHAN DEEPIKA | Director | 16 | $0 | $466.2K | 2026-02-26 |
| WYZGA MICHAEL S | Director | 6 | $0 | $0 | 2026-02-26 |
| Hughes-Wilson Alexandra | See Remarks | 27 | $0 | $1.05M | 2026-02-01 |
| Fox Christine Ann | Chief Financial Officer | 13 | $0 | $269.4K | 2026-02-01 |
| Sermon Charles | General Counsel | 13 | $0 | $294.5K | 2026-02-01 |
| Lewicki John A. | Chief Scientific Officer | 13 | $0 | $153.8K | 2026-02-01 |
| Scots-Knight Denise | Chief Executive Officer | 13 | $0 | $844.3K | 2026-02-01 |
| Rubric Capital Management LP | 10% Owner | 1 | $0 | $0 | 2024-06-17 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| WYZGA MICHAEL S | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 66,000 | — | $0 | 66,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 66,000 | — | $0 | 66,000 | SEC↗ |
| Ekblom Anders | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 133,560 | — | $0 | 133,560 | SEC↗ |
| Ekblom Anders | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 66,000 | — | $0 | 66,000 | SEC↗ |
| Shames Daniel | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 96,163 | — | $0 | 96,163 | SEC↗ |
| Shames Daniel | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 66,000 | — | $0 | 66,000 | SEC↗ |
| Yoskowitz Marc J | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 66,000 | — | $0 | 66,000 | SEC↗ |
| Yoskowitz Marc J | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 96,163 | — | $0 | 96,163 | SEC↗ |
| Jacquet Pierre | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 66,000 | — | $0 | 66,000 | SEC↗ |
| Jacquet Pierre | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 106,848 | — | $0 | 106,848 | SEC↗ |
| Jenkins Annalisa | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 66,000 | — | $0 | 66,000 | SEC↗ |
| Jenkins Annalisa | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 106,848 | — | $0 | 106,848 | SEC↗ |
| Bender Jeremy | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 117,533 | — | $0 | 117,533 | SEC↗ |
| Bender Jeremy | Director | A Award deriv | 2026-02-26 | 2026-02-27 | 66,000 | — | $0 | 66,000 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | A Award deriv | 2026-02-01 | 2026-02-02 | 105,250 | — | $0 | 105,250 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | A Award deriv | 2026-02-01 | 2026-02-02 | 315,750 | — | $0 | 315,750 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | A Award deriv | 2026-02-01 | 2026-02-02 | 280,000 | — | $0 | 280,000 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | A Award deriv | 2026-02-01 | 2026-02-02 | 480,000 | — | $0 | 480,000 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | A Award deriv | 2026-02-01 | 2026-02-02 | 1,035,000 | — | $0 | 1,035,000 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | A Award deriv | 2026-02-01 | 2026-02-02 | 345,000 | — | $0 | 345,000 | SEC↗ |
| Sermon Charles | General Counsel | A Award deriv | 2026-02-01 | 2026-02-02 | 295,000 | — | $0 | 295,000 | SEC↗ |
| Sermon Charles | General Counsel | A Award deriv | 2026-02-01 | 2026-02-02 | 315,750 | — | $0 | 315,750 | SEC↗ |
| Sermon Charles | General Counsel | A Award deriv | 2026-02-01 | 2026-02-02 | 105,250 | — | $0 | 105,250 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | A Award deriv | 2026-02-01 | 2026-02-02 | 195,000 | — | $0 | 195,000 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | A Award deriv | 2026-02-01 | 2026-02-02 | 183,750 | — | $0 | 183,750 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | A Award deriv | 2026-02-01 | 2026-02-02 | 61,250 | — | $0 | 61,250 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | A Award deriv | 2026-02-01 | 2026-02-02 | 145,000 | — | $0 | 145,000 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | A Award deriv | 2026-02-01 | 2026-02-02 | 139,913 | — | $0 | 139,913 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | A Award deriv | 2026-02-01 | 2026-02-02 | 46,637 | — | $0 | 46,637 | SEC↗ |
| Jenkins Annalisa | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Jenkins Annalisa | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 15,243 | — | $0 | 15,243 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 30,487 | — | $0 | 30,487 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Ekblom Anders | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 19,054 | — | $0 | 19,054 | SEC↗ |
| Ekblom Anders | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Yoskowitz Marc J | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Yoskowitz Marc J | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 13,719 | — | $0 | 13,719 | SEC↗ |
| Jacquet Pierre | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 15,243 | — | $0 | 15,243 | SEC↗ |
| Jacquet Pierre | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Shames Daniel | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Shames Daniel | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 13,719 | — | $0 | 13,719 | SEC↗ |
| Bender Jeremy | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 16,768 | — | $0 | 16,768 | SEC↗ |
| Bender Jeremy | Director | A Award deriv | 2025-02-05 | 2025-02-06 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | A Award deriv | 2025-01-25 | 2025-01-28 | 825,000 | — | $0 | 825,000 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | A Award deriv | 2025-01-25 | 2025-01-28 | 154,000 | — | $0 | 154,000 | SEC↗ |
| Sermon Charles | General Counsel | A Award deriv | 2025-01-25 | 2025-01-28 | 262,000 | — | $0 | 262,000 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | A Award deriv | 2025-01-25 | 2025-01-28 | 116,000 | — | $0 | 116,000 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | A Award deriv | 2025-01-25 | 2025-01-28 | 262,000 | — | $0 | 262,000 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | S Sale | 2024-09-13 | 2024-09-16 | 16,304 | $4.22 | $68.8K | 134,483 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | S Sale | 2024-09-13 | 2024-09-16 | 84,008 | $4.22 | $354.5K | 50,475 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | S Sale | 2024-09-13 | 2024-09-16 | 19,158 | $4.22 | $80.8K | 89,285 | SEC↗ |
| Sermon Charles | General Counsel | S Sale | 2024-09-13 | 2024-09-16 | 20,946 | $4.22 | $88.4K | 219,061 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | S Sale | 2024-09-13 | 2024-09-16 | 10,937 | $4.22 | $46.2K | 78,630 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | S Sale | 2024-09-13 | 2024-09-16 | 60,046 | $4.22 | $253.4K | 808,921 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | S Sale | 2024-09-12 | 2024-09-16 | 7,769 | $4.47 | $34.7K | 190,816 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | S Sale | 2024-09-12 | 2024-09-16 | 40,029 | $4.47 | $178.9K | 150,787 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | S Sale | 2024-09-12 | 2024-09-16 | 9,128 | $4.47 | $40.8K | 108,443 | SEC↗ |
| Sermon Charles | General Counsel | S Sale | 2024-09-12 | 2024-09-16 | 9,980 | $4.47 | $44.6K | 240,007 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | S Sale | 2024-09-12 | 2024-09-16 | 5,212 | $4.47 | $23.3K | 89,567 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | S Sale | 2024-09-12 | 2024-09-16 | 28,611 | $4.47 | $127.9K | 868,967 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise deriv | 2024-09-11 | 2024-09-13 | 40,000 | — | $0 | 0 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise deriv | 2024-09-11 | 2024-09-13 | 75,000 | $1.01 | $75.8K | 0 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise deriv | 2024-09-11 | 2024-09-13 | 93,333 | $1.40 | $130.7K | 0 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | M Exercise deriv | 2024-09-11 | 2024-09-13 | 188,060 | — | $0 | 0 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | M Exercise deriv | 2024-09-11 | 2024-09-13 | 46,000 | — | $0 | 0 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | M Exercise deriv | 2024-09-11 | 2024-09-13 | 60,000 | — | $0 | 0 | SEC↗ |
| Sermon Charles | General Counsel | M Exercise deriv | 2024-09-11 | 2024-09-13 | 65,600 | — | $0 | 0 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise | 2024-09-11 | 2024-09-13 | 75,000 | $1.01 | $75.8K | 242,881 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise | 2024-09-11 | 2024-09-13 | 40,000 | — | $0 | 74,548 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise | 2024-09-11 | 2024-09-13 | 93,333 | $1.40 | $130.7K | 167,881 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | M Exercise | 2024-09-11 | 2024-09-13 | 188,060 | — | $0 | 897,578 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | M Exercise | 2024-09-11 | 2024-09-13 | 46,000 | — | $0 | 94,779 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | M Exercise | 2024-09-11 | 2024-09-13 | 60,000 | — | $0 | 117,571 | SEC↗ |
| Sermon Charles | General Counsel | M Exercise | 2024-09-11 | 2024-09-13 | 65,600 | — | $0 | 249,987 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise deriv | 2024-08-22 | 2024-08-23 | 11,000 | — | $0 | 0 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise deriv | 2024-08-22 | 2024-08-23 | 5,500 | — | $0 | 0 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise deriv | 2024-08-22 | 2024-08-23 | 31,500 | — | $0 | 0 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise deriv | 2024-08-22 | 2024-08-23 | 55,000 | — | $0 | 0 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise deriv | 2024-08-22 | 2024-08-23 | 15,000 | — | $0 | 30,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise deriv | 2024-08-22 | 2024-08-23 | 55,000 | — | $0 | 0 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise | 2024-08-22 | 2024-08-23 | 1,825 | $3.00 | $5.5K | 1,825 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | S Sale | 2024-08-22 | 2024-08-23 | 105,244 | $4.43 | $466.2K | 0 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise | 2024-08-22 | 2024-08-23 | 6,492 | $1.84 | $11.9K | 8,317 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise | 2024-08-22 | 2024-08-23 | 38,953 | $1.31 | $51.0K | 59,688 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise | 2024-08-22 | 2024-08-23 | 12,418 | $2.72 | $33.8K | 20,735 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise | 2024-08-22 | 2024-08-23 | 2,071 | $3.87 | $8.0K | 105,244 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | M Exercise | 2024-08-22 | 2024-08-23 | 43,485 | $0.94 | $40.9K | 103,173 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | S Sale | 2024-06-26 | 2024-06-27 | 22,968 | $3.39 | $77.9K | 34,548 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | S Sale | 2024-06-26 | 2024-06-27 | 92,273 | $3.39 | $312.8K | 709,518 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | S Sale | 2024-06-26 | 2024-06-27 | 29,439 | $3.39 | $99.8K | 57,571 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | S Sale | 2024-06-26 | 2024-06-27 | 16,808 | $3.39 | $57.0K | 48,779 | SEC↗ |
| Sermon Charles | General Counsel | S Sale | 2024-06-26 | 2024-06-27 | 32,187 | $3.39 | $109.1K | 184,387 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | S Sale | 2024-06-25 | 2024-06-27 | 10,134 | $3.69 | $37.4K | 57,516 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | S Sale | 2024-06-25 | 2024-06-27 | 40,712 | $3.69 | $150.2K | 801,791 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | S Sale | 2024-06-25 | 2024-06-27 | 12,990 | $3.69 | $47.9K | 87,010 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | S Sale | 2024-06-25 | 2024-06-27 | 7,416 | $3.69 | $27.4K | 65,587 | SEC↗ |
| Sermon Charles | General Counsel | S Sale | 2024-06-25 | 2024-06-27 | 14,202 | $3.69 | $52.4K | 216,574 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise deriv | 2024-06-21 | 2024-06-25 | 60,000 | — | $0 | 40,000 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | M Exercise deriv | 2024-06-21 | 2024-06-25 | 90,000 | — | $0 | 60,000 | SEC↗ |
| Sermon Charles | General Counsel | M Exercise deriv | 2024-06-21 | 2024-06-25 | 98,400 | — | $0 | 65,600 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | M Exercise deriv | 2024-06-21 | 2024-06-25 | 282,090 | — | $0 | 188,060 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | M Exercise deriv | 2024-06-21 | 2024-06-25 | 69,000 | — | $0 | 46,000 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise | 2024-06-21 | 2024-06-25 | 60,000 | — | $0 | 67,650 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | M Exercise | 2024-06-21 | 2024-06-25 | 90,000 | — | $0 | 100,000 | SEC↗ |
| Sermon Charles | General Counsel | M Exercise | 2024-06-21 | 2024-06-25 | 98,400 | — | $0 | 230,776 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | M Exercise | 2024-06-21 | 2024-06-25 | 282,090 | — | $0 | 842,503 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | M Exercise | 2024-06-21 | 2024-06-25 | 69,000 | — | $0 | 73,003 | SEC↗ |
| Rubric Capital Management LP | 10% Owner | A Award deriv | 2024-06-17 | 2024-06-17 | 1,754,350 | $3.99 | $7.00M | 15,307,347 | SEC↗ |
| Bender Jeremy | Director | A Award | 2024-06-17 | 2024-06-17 | 12,550 | $3.99 | $50.1K | 12,550 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award | 2024-06-17 | 2024-06-17 | 25,050 | $3.99 | $99.9K | 25,050 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise deriv | 2024-05-22 | 2024-05-23 | 75,000 | $1.01 | $75.8K | 0 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise deriv | 2024-05-22 | 2024-05-23 | 93,333 | $1.40 | $130.7K | 0 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | S Sale | 2024-05-22 | 2024-05-23 | 50,082 | $2.94 | $147.2K | 32,568 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise | 2024-05-22 | 2024-05-23 | 75,000 | $1.01 | $75.8K | 82,650 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | F Tax w/h | 2024-05-22 | 2024-05-23 | 42,983 | $1.40 | $60.2K | 7,650 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | S Sale | 2024-05-22 | 2024-05-23 | 50,350 | $2.99 | $150.5K | 58,633 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | M Exercise | 2024-05-22 | 2024-05-23 | 93,333 | $1.40 | $130.7K | 100,983 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | F Tax w/h | 2024-05-22 | 2024-05-23 | 24,918 | $1.01 | $25.2K | 7,650 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 30,783 | — | $0 | 30,783 | SEC↗ |
| WYZGA MICHAEL S | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Jacquet Pierre | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Jacquet Pierre | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 15,553 | — | $0 | 15,553 | SEC↗ |
| Shames Daniel | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 14,139 | — | $0 | 14,139 | SEC↗ |
| Shames Daniel | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Bender Jeremy | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Bender Jeremy | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 16,361 | — | $0 | 16,361 | SEC↗ |
| Yoskowitz Marc J | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 14,139 | — | $0 | 14,139 | SEC↗ |
| Yoskowitz Marc J | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PAKIANATHAN DEEPIKA | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Ekblom Anders | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 19,471 | — | $0 | 19,471 | SEC↗ |
| Ekblom Anders | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Jenkins Annalisa | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 14,947 | — | $0 | 14,947 | SEC↗ |
| Jenkins Annalisa | Director | A Award deriv | 2024-02-08 | 2024-02-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Scots-Knight Denise | Chief Executive Officer | A Award deriv | 2024-01-25 | 2024-01-26 | 850,000 | — | $0 | 850,000 | SEC↗ |
| Lewicki John A. | Chief Scientific Officer | A Award deriv | 2024-01-25 | 2024-01-26 | 137,000 | — | $0 | 137,000 | SEC↗ |
| Hughes-Wilson Alexandra | See Remarks | A Award deriv | 2024-01-25 | 2024-01-26 | 196,000 | — | $0 | 196,000 | SEC↗ |
| Fox Christine Ann | Chief Financial Officer | A Award deriv | 2024-01-25 | 2024-01-26 | 245,000 | — | $0 | 245,000 | SEC↗ |
| Sermon Charles | General Counsel | A Award deriv | 2024-01-25 | 2024-01-26 | 245,000 | — | $0 | 245,000 | SEC↗ |